Citations

Clear

344 citation(s) found for "ASIRVATHAM, SAMUEL".

Cardioembolic Stroke in Patients with Patent Foramen Ovale and Implanted Cardiac Leads
Hagler, Donald J. , Friedman, Paul A. , Asirvatham, Samuel J. , DeSimone, Christopher V. , DeSimone, Daniel C. , Asirvatham, Samuel J

Mayo Clinic

Pacing and Clinical Electrophysiology | October 19, 2012 | Volume: 36 | Issue: 1 | Pages: 50-54

10.1111/pace.12014 | PMID 23077982 Get It

Implanted cardiac devices, including pacemakers, defibrillators, and resynchronization devices, are known to develop thrombus on their intravascular leads. Patent foramen ovale (PFO) occurs in approximately one‐quarter of the adult population. It is unclear whether paradoxical cardioembolism and clinically relevant stroke occur in patients with implanted cardiac leads and PFO. We present a case series of four patients with cardioembolic stroke, presumed to arise from intravascular cardiac leads and associated PFO that required device closure of the PFO.(PACE 2013; 36:50–54)
Signals
Madhavan, Malini , Govil, Shalini, Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 14, 2012 | Volume: 5 | Issue: 1 | Pages: 2-4

10.1161/circep.112.970509 | PMID 22334427 Get It

P-425 Utility of non-contact mapping technique for identification and ablation of non-pulmonary vein foci
Leite, Luiz, Monahan, Kristi H. , Sarabanda, Álvaro Valentim Lima , Peterson, Lori Ann, Bluhm, Christine M., Munger, Thomas M. , Packer, D. L., Asirvatham, Samuel J.

Mayo Clinic

EP Europace | January 31, 2012 | Volume: 4 | Issue: Supplement_2 | Pages: B166-B166

10.1016/eupace/4.supplement_2.b166-b Get It

Signals and Signal Processing for the Electrophysiologist
Venkatachalam, K, Herbrandson, Joel E., Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | December 21, 2011 | Volume: 4 | Issue: 6 | Pages: 974-981

10.1161/circep.111.964973 | PMID 22203662 Get It

Signals and Signal Processing for the Electrophysiologist
Venkatachalam, K, Herbrandson, Joel E., Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | December 21, 2011 | Volume: 4 | Issue: 6 | Pages: 965-973

10.1161/circep.111.964304 | PMID 22203661 Get It

Teaching Points With 3-Dimensional Mapping of Cardiac Arrhythmia
Muñoz, Freddy Del Carpio, Buescher, Traci L., Asirvatham, Samuel J. , Munoz, Freddy Del‐Carpio , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | December 21, 2011 | Volume: 4 | Issue: 6 | Pages: No page available

10.1161/circep.110.960369 | PMID 22203663 Get It

Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction
Cha, Yong-Mei , Wokhlu, Anita , Asirvatham, Samuel J. , Shen, Win‐Kuang , Friedman, Paul A. , Munger, Thomas M. , Oh, Jae K. , Monahan, Kristi H. , Haroldson, Janis M., Hodge, David O. , Herges, Regina M., Hammill, Stephen C., Packer, Douglas L. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | July 12, 2011 | Volume: 4 | Issue: 5 | Pages: 724-732

10.1161/circep.110.960690 | PMID 21747059 Get It

Background— The efficacy of radiofrequency ablation for atrial fibrillation (AF) in patients with left ventricular (LV) systolic dysfunction and isolated diastolic dysfunction is uncertain. Methods and Results— A prospective cohort of patients with normal and abnormal LV function underwent ablation for antiarrhythmic drug (AAD)-refractory AF. Three groups were compared: 111 patients with systolic dysfunction, defined as LV ejection fraction (LVEF) ≤40%; 157 patients with isolated diastolic dysfunction but preserved LVEF ≥50%; and 100 patients with normal LV function. The primary end point was AAD-free AF elimination at 1 year after ablation. This end point was achieved in 62% of patients with systolic dysfunction, 75% of those with diastolic dysfunction, and 84% of controls ( P =0.007). AF control on or off AADs was achieved in 76% of patients with systolic dysfunction, 85% of those with diastolic dysfunction, and 89% of controls ( P =0.08). In the systolic dysfunction group, 49% experienced an increase in LVEF by ≥5% after ablation, of which 64% achieved normal LVEF. In the diastolic dysfunction group, 30% of patients demonstrated at least 1 grade improvement in diastolic dysfunction. Multivariable analysis demonstrated an increased relative risk of arrhythmia recurrence of 1.8 (95% CI, 1.1 to 3.1; P =0.02) in systolic dysfunction and 1.7 (1.0 to 2.7; P =0.04) in isolated diastolic dysfunction compared with normal function. Conclusions— Although an ablative approach for AF in patients with systolic or diastolic dysfunction is associated with an increased long-term recurrence risk, there is potential for substantial quality-of-life improvement and LV functional benefit.
Teaching Points With 3-Dimensional Mapping of Cardiac Arrhythmias
Muñoz, Freddy Del Carpio, Buescher, Traci L., Asirvatham, Samuel J. , Munoz, Freddy Del‐Carpio , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | June 15, 2011 | Volume: 4 | Issue: 3 | Pages: No page available

10.1161/circep.110.960351 | PMID 21673021 Get It

The “Slow Pathway” Potential: Fact or Fiction?
Gard, Joseph J., Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | April 19, 2011 | Volume: 4 | Issue: 2 | Pages: 125-127

10.1161/circep.111.962662 | PMID 21505175 Get It

Teaching Points With 3-Dimensional Mapping of Cardiac Arrhythmias
Muñoz, Freddy Del Carpio, Buescher, Traci L., Asirvatham, Samuel J. , Munoz, Freddy Del‐Carpio , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | April 19, 2011 | Volume: 4 | Issue: 2 | Pages: No page available

10.1161/circep.110.960344 | PMID 21505169 Get It